Table 2 .
Estimated impact of ABC management on outcomes and costs for AF patients in 2030 and 2040
% of AF patients managed on ABC pathway | |||||||||
---|---|---|---|---|---|---|---|---|---|
20 | 30 | 40 | 50 | 60 | 70 | 80 | 90 | 100 | |
2030 | |||||||||
Strokes prevented | 2758 | 4137 | 5516 | 6895 | 8274 | 9653 | 11 032 | 12 411 | 13 790 |
Cost reduction (£)—strokes | 59 908 339 | 89 862 509 | 119 816 679 | 149 770 848 | 179 725 018 | 209 679 188 | 239 633 357 | 269 587 527 | 299 541 697 |
Bleeds prevented | 3983 | 5974 | 7965 | 9956 | 11 948 | 13 939 | 15 930 | 17 921 | 19 913 |
Cost reduction (£)—bleeds | 27 518 672 | 41 278 008 | 55 037 344 | 68 796 680 | 82 556 015 | 96 315 351 | 110 074 687 | 123 834 023 | 137 593 359 |
Cost reduction (£)—total | 87 427 011 | 131 140 517 | 174 854 022 | 218 567 528 | 262 281 033 | 305 994 539 | 349 708 044 | 393 421 550 | 437 135 056 |
Deaths prevented (all cause) | 11 945 | 17 918 | 23 890 | 29 863 | 35 836 | 41 808 | 47 781 | 53 754 | 59 726 |
Deaths prevented (CV) | 6043 | 9064 | 12 086 | 15 107 | 18 129 | 21 150 | 24 172 | 27 193 | 30 214 |
2040 | |||||||||
Strokes prevented | 3724 | 5586 | 7449 | 9311 | 11 173 | 13 035 | 14 897 | 16 759 | 18 622 |
Cost reduction (£)—strokes | 98 615 026 | 147 922 539 | 197 230 052 | 246 537 565 | 295 845 078 | 345 152 591 | 394 460 104 | 443 767 617 | 493 075 130 |
Bleeds prevented | 5378 | 8067 | 10 756 | 13 445 | 16 134 | 18 823 | 21 512 | 24 201 | 26 890 |
Cost reduction (£)—bleeds | 45 298 444 | 67 947 666 | 90 596 888 | 113 246 109 | 135 895 331 | 158 544 553 | 181 193 775 | 203 842 997 | 226 492 219 |
Cost reduction (£)—total | 143 913 470 | 215 870 205 | 287 826 940 | 359 783 675 | 431 740 409 | 503 697 144 | 575 653 879 | 647 610 614 | 719 567 349 |
Deaths prevented (all cause) | 16 131 | 24 196 | 32 261 | 40 326 | 48 392 | 56 457 | 64 522 | 72 587 | 80 653 |
Deaths prevented (CV) | 8160 | 12 240 | 16 320 | 20 400 | 24 481 | 28 561 | 32 641 | 36 721 | 40 801 |
CV = cardiovascular